Eversept Partners, LP
NEW YORK, NY · CIK 1697013 · 13F filing filed 2023-11-08
SEC-registered investment adviser since 2017 · limited partnership
- Assets managed$2.7bn
- Staff10 · 5 in investment roles
- Main clients (by assets)Private funds 99%, Mutual funds and ETFs 1%
- Private funds3 (3 hedge) · $2.3bn gross assets
- Websiteeversept.com
- Form ADV · 2026-03-31SEC adviser record
- Legal entityEVERSEPT PARTNERS, L.P. (US)
- Kindhedge funds, futures
- Others nearbyNew York, NY, San Francisco, CA
As an employer
- Offices in1 country
- Private fundshedge 3
Where they work
Offices
From Form ADV: the main office and the other offices where it does advisory work (at most the 25 largest), with the people doing investment work at each. “About” is worked out: the firm's investment staff less its other offices. Each city links to the other managers there.
| City | People |
|---|---|
| New York, NY (main office)United States | about 4 |
| San Francisco, CAUnited States | 1 |
Map: places from GeoNames (CC BY 4.0), outlines from Natural Earth.
Options: 11 call positions ($199.4m notional), 7 put positions ($221.1m notional) – listed below, not included above.
Holdings, Q2 2021
The small lines show how much was held over the last 4 quarters (adjusted for stock splits).
| Security | Value | Change |
|---|---|---|
| UNITED THERAPEUTICS CORP DEL UTHR | $79.5m7.36% | Reduced -43.6k |
| AMARIN CORP PLC SPONS ADR NEW | $73.0m6.76% | Reduced -227.3k |
| ARK ETF TR ARKG | $71.5m6.63% | Reduced -33.5k |
| HORIZON THERAPEUTICS PUB L HZNP | $62.4m5.78% | Reduced -28.7k |
| ASTRAZENECA PLC SPONSORED ADR | $59.0m5.47% | Reduced -6.6k |
| COMMUNITY HEALTH SYS INC NEW CYH | $59.0m5.46% | Added +1.4m |
| DANAHER CORPORATION DHR | $55.0m5.09% | Added +27.2k |
| ACCELERON PHARMA INC XLRN | $42.0m3.89% | Added +93.1k |
| TEVA PHARMACEUTICAL INDS LTD SPONSORED ADS | $37.7m3.49% | Reduced -550.4k |
| AVANTOR INC AVTR | $34.6m3.21% | Added +15.7k |
| BRISTOL-MYERS SQUIBB CO BMY | $32.0m2.96% | New |
| ASCENDIS PHARMA A/S SPONSORED ADR | $31.8m2.95% | Reduced -70.1k |
| QIAGEN NV SHS NEW | $31.5m2.92% | Added +196.3k |
| FATE THERAPEUTICS INC FATE | $30.1m2.78% | Added +24.6k |
| ORTHO CLINICAL DIAGNOSTICS H OCDX | $29.9m2.76% | Added +19.1k |
| AMNEAL PHARMACEUTICALS INC AMRX | $28.8m2.67% | Added +869.2k |
| ENVISTA HOLDINGS CORPORATION NVST | $28.3m2.63% | Reduced -76.6k |
| ORGANON & CO OGN | $21.2m1.96% | New |
| IONIS PHARMACEUTICALS INC IONS | $17.6m1.63% | New |
| R1 RCM INC RCM | $17.1m1.59% | New |
| HEALTHEQUITY INC HQY | $15.9m1.47% | New |
| AMN HEALTHCARE SVCS INC AMN | $15.4m1.43% | New |
| OMNICELL COM OMCL | $14.9m1.38% | New |
| MCKESSON CORP MCK | $14.4m1.33% | Reduced -48.0k |
| TARO PHARMACEUTICAL INDS LTD TARO | $12.5m1.16% | Added +9.9k |
| ARK ETF TR ARKK | $11.1m1.03% | Added +3.0k |
| VERTEX PHARMACEUTICALS INC VRTX | $11.0m1.02% | New |
| THE CIGNA GROUP CI | $9.9m0.92% | Added +1.7k |
| MAGELLAN HEALTH INC MGLN | $9.9m0.91% | Unchanged |
| ALNYLAM PHARMACEUTICALS INC ALNY | $8.7m0.80% | Reduced -29.8k |
| ZOGENIX INC ZGNX | $8.6m0.79% | Reduced -327.4k |
| HUMANA INC HUM | $8.3m0.77% | Reduced -6.2k |
| OPTION CARE HEALTH INC OPCH | $6.3m0.59% | New |
| OUTSET MED INC OM | $5.4m0.50% | New |
| CENTENE CORP DEL CNC | $5.0m0.46% | Reduced -23.1k |
| SURGALIGN HOLDINGS INC RTIX | $4.9m0.45% | Added +1.2m |
| AFFIMED N V COM | $4.8m0.45% | Reduced -479.2k |
| INTRA-CELLULAR THERAPIES INC ITCI | $4.8m0.44% | Reduced -183.1k |
| GLAXOSMITHKLINE PLC SPONSORED ADR | $4.6m0.43% | Reduced -739.5k |
| CULLINAN THERAPEUTICS INC CGEM | $4.2m0.39% | New |
| DEXCOM INC DXCM | $4.1m0.38% | Reduced -9.2k |
| ELEVANCE HEALTH INC ELV | $3.9m0.36% | Reduced -53.8k |
| KADMON HLDGS INC KDMN | $3.5m0.32% | Reduced -478.1k |
| EXELIXIS INC EXEL | $3.3m0.30% | New |
| AUTOLUS THERAPEUTICS PLC AUTL | $3.1m0.29% | New |
| MARAVAI LIFESCIENCES HLDGS I MRVI | $3.1m0.29% | New |
| INTERSECT ENT INC XENT | $3.0m0.28% | Added +100.0k |
| CENTURY THERAPEUTICS INC IPSC | $3.0m0.27% | New |
| LIQUIDIA CORPORATION LQDA | $2.8m0.26% | Added +479.0k |
| TG THERAPEUTICS INC TGTX | $2.7m0.25% | Reduced -692.8k |
| INTUITIVE SURGICAL INC ISRG | $2.4m0.22% | Unchanged |
| AGILENT TECHNOLOGIES INC A | $2.3m0.21% | Unchanged |
| HEALTHSTREAM INC HSTM | $2.2m0.20% | New |
| OCULAR THERAPEUTIX INC OCUL | $2.1m0.20% | New |
| ALPHA HEALTHCARE ACQUISTN CO CL A | $2.1m0.19% | Reduced -34.0k |
| HCA HEALTHCARE INC HCA | $1.7m0.16% | Reduced -77.1k |
| SERES THERAPEUTICS INC COM | $1.4m0.13% | Reduced -155.7k |
| IQVIA HLDGS INC IQV | $1.4m0.13% | Reduced -209 |
| TELIGENT INC NEW COM NEW | $1.3m0.12% | Unchanged |
| IMMUNOVANT INC IMVT | $1.2m0.11% | Reduced -120.0k |
| NATERA INC NTRA | $1.1m0.10% | Reduced -48.4k |
| LEXICON PHARMACEUTICALS INC LXRX | $1.1m0.10% | Reduced -181.3k |
| F-STAR THERAPEUTICS INC COM | $859.0k0.08% | New |
| HESKA CORP HSKA | $783.8k0.07% | Reduced -7.6k |
| ENSIGN GROUP INC ENSG | $778.2k0.07% | Reduced -19.9k |
| GOHEALTH INC COM CL A | $772.4k0.07% | Unchanged |
| REPLIGEN CORP RGEN | $737.0k0.07% | Added +2.3k |
| CROSS CTRY HEALTHCARE INC CCRN | $508.7k0.05% | New |
| GUARDANT HEALTH INC GH | $224.7k0.02% | Reduced -38.4k |
Sold out since Q1 2021
| Security | Value then |
|---|---|
| ALEXION PHARMACEUTICALS INC ALXN | $71.3m466.0k shares |
| CATALENT INC CTLT | $17.2m163.1k shares |
| BECTON DICKINSON & CO BDX | $16.6m68.4k shares |
| BIOHAVEN PHARMACTL HLDG CO L BHVN | $16.6m242.2k shares |
| DECIPHERA PHARMACEUTICALS IN DCPH | $15.5m345.7k shares |
| ACADIA PHARMACEUTICALS INC ACAD | $10.8m420.0k shares |
| ARGENX SE ARGX | $9.9m35.9k shares |
| MANNKIND CORP MNKD | $8.5m2.2m shares |
| NOVAVAX INC NVAX | $6.1m33.5k shares |
| LUMINEX CORP DEL | $4.3m135.5k shares |
| FIVE PRIME THERAPEUTICS INC FPRX | $3.5m93.3k shares |
| SURMODICS INC SRDX | $2.7m47.9k shares |
| EXAGEN INC XGN | $1.8m104.4k shares |
| PROTHENA CORP PLC PRTA | $1.7m68.6k shares |
| KEROS THERAPEUTICS INC KROS | $1.7m27.6k shares |
| CONFORMIS INC CFMS | $1.5m1.5m shares |
| CHEWY INC CHWY | $1.1m13.1k shares |
| RITE AID CORP RAD | $1.1m54.0k shares |
| INFLARX NV IFRX | $1.0m268.6k shares |
| CABALETTA BIO INC CABA | $853.0k76.8k shares |
| IMMUTEP LTD | $767.2k249.9k shares |
| APELLIS PHARMACEUTICALS INC APLS | $553.5k12.9k shares |
| QUIDEL CORP QDEL | $528.6k4.1k shares |
| APTOSE BIOSCIENCES INC | $478.0k80.0k shares |
Options (notional value)
| Underlying | Notional | Change |
|---|---|---|
| SPDR S&P 500 ETF TR SPY · Put | $107.0m250.0k shares | Added |
| INVESCO QQQ TR QQQ · Put | $88.6m250.0k shares | New |
| GLAXOSMITHKLINE PLC Call | $55.9m1.4m shares | Added |
| BIOGEN INC BIIB · Call | $40.0m115.6k shares | New |
| VERTEX PHARMACEUTICALS INC VRTX · Call | $34.9m173.3k shares | Added |
| SPDR SER TR XBI · Call | $27.1m200.0k shares | New |
| ARK ETF TR ARKG · Call | $18.4m199.0k shares | New |
| SPDR SER TR XBI · Put | $13.5m100.0k shares | New |
| ISHARES TR TIP · Put | $9.0m70.0k shares | New |
| TELADOC HEALTH INC TDOC · Call | $6.7m40.0k shares | New |
| HORIZON THERAPEUTICS PUB L HZNP · Call | $6.6m70.0k shares | New |
| MERCK & CO INC MRK · Call | $3.8m48.7k shares | New |
| NOVAVAX INC NVAX · Call | $2.1m10.0k shares | Unchanged |
| ACADIA PHARMACEUTICALS INC ACAD · Call | $2.1m84.6k shares | Added |
| TEVA PHARMACEUTICAL INDS LTD Call | $1.9m192.9k shares | New |
| GLOBAL BLOOD THERAPEUTICS IN GBT · Put | $1.4m40.0k shares | New |
| FREQUENCY THERAPEUTICS INC Put | $921.3k92.5k shares | Reduced |
| BIOGEN INC BIIB · Put | $692.5k2.0k shares | New |
Stakes above 5%
Companies where this manager has reported owning more than 5% of a class of shares, on Schedule 13D (may seek influence) or 13G (passive): its latest filing for each, from 19 Dec 2024 on.
| Company | Stake |
|---|---|
| COMMUNITY HEALTH SYS INC NEW CYH · 13G · filed 2026-02-17 | 5.7%≈ $26.5m |